Literature DB >> 33553405

Radical resection of hepatic polycystic echinococcosis complicated with hepatocellular carcinoma: A case report.

Baheti Kalifu1, Yuan Meng1, Yusufukadier Maimaitinijiati1, Zhi-Gang Ma1, Guang-Lei Tian1, Jin-Guo Wang1, Xiong Chen2.   

Abstract

BACKGROUND: Hepatic cystic echinococcosis (CE) is an infectious zoonotic parasitic disease, and the insidious onset and slow progression of hepatic CE usually contributes to delayed diagnosis and treatment. Hepatocellular carcinoma (HCC) is the fourth most common malignant tumor. Co-existence of CE and HCC is fairly rare in clinical settings and the association between the two is still not well recognized. We report a case of hepatic CE complicated with HCC which are radically resected and raise some questions worth thinking about. CASE
SUMMARY: A 70-year-old man presented with upper abdominal pain. On admission, laboratory data showed that, except for hepatitis B surface antigen positivity, other indicators were normal, including alpha-fetoprotein. Computed tomography of the abdomen revealed a huge polycystic lesion in left liver lobe, without reinforcement after enhanced scanning and sized about 16.9 cm × 12.2 cm, which was considered a type II hydatid cyst. Multiple small solid lesions were also found adjacent to it, and thus it was highly suspected as a malignant tumor. After a multidisciplinary team discussion, the diagnosis of co-occurrence of hepatic CE and HCC was made. According to Romic classification, the case belongs to type IIb, and radical left hemi-hepatectomy was performed. Postoperative pathological examination revealed CE co-existence with well-differentiated HCC, consistent with the preoperative diagnosis.
CONCLUSION: With the combination of hepatitis B and obvious extrusion by large hydatid, the HCC risk of a patient might be higher. ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.

Entities:  

Keywords:  Case report; Co-existence; Cystic echinococcosis; Hepatitis B; Hepatocellular carcinoma; Parasitic disease; Radical resection

Year:  2021        PMID: 33553405      PMCID: PMC7829736          DOI: 10.12998/wjcc.v9.i3.659

Source DB:  PubMed          Journal:  World J Clin Cases        ISSN: 2307-8960            Impact factor:   1.337


Core Tip: Hepatic cystic echinococcosis (CE) is an infectious zoonotic parasitic disease, hepatocellular carcinoma (HCC) is the fourth most common malignant tumor. Co-existence of CE and HCC is fairly rare in clinical settings and the association between the two is still not well recognized. We report a case of hepatic CE complicated with HCC which are radically resected, and present an opinion that with the combination of hepatitis B and obvious extrusion by large hydatid, the HCC risk of the patients might be higher.

INTRODUCTION

Cystic echinococcosis (CE) is caused by Echinococcus granulosus (E. granulosus), an infectious parasitic disease. Liver is the most affected organ due to the special life cycle of E. granulosus[1,2]. In recent years, with the development of tourism and the movement of populations, hepatic CE has become a serious public health problem around the world. In endemic areas, the incidence of cystic hydatid disease is 1-200/100000 per year, and fatality rate has been reported as 2%-4%[3]. Hepatocellular carcinoma (HCC) is the most frequent primary liver cancer, accounting for more than 85%-90% of them, and is a leading cause of cancer-related mortality[4]. Although both are hepatic space-occupying diseases, it is rare to co-occur, due to their biological characteristics. There have been few reports concerning hepatic CE accompanied by HCC[5,6]. Whether hydatid infection impacts the occurrence and progression of HCC is still unclear. Here, we share a case of huge hepatic CE lesion complicated with HCC, and present some controversial issues with detailed discussion.

CASE PRESENTATION

Chief complaints

A 70-year-old man presented to The Department of Hepatobiliary Surgery, People’s Hospital of Xinjiang Uygur Autonomous Region, with complaint of upper abdominal pain for 2 wk.

History of present illness

The patient had upper abdominal pain for 2 wk, and no another special discomfort symptom.

History of past illness

The patient had no significant past illness.

Personal and family history

The patient had no significant personal and family history.

Physical examination

The physical examination was significant for pain in the right upper quadrant upon palpation.

Laboratory examinations

All laboratory testing, including glutamic-pyruvic transaminase, glutamic-oxalacetic transaminase, gamma-glutamyl transpeptidase, and alpha-fetoprotein, was normal, except for positivity for hepatitis B surface antigen.

Imaging examinations

Computed tomography of the abdomen revealed a huge polycystic lesion in left liver lobe, without reinforcement after enhanced scanning, sized about 16.9 cm × 12.2 cm (Figure 1), which was considered a type II hydatid cyst[7]. Multiple small solid lesions were also found adjacent to it, and thus it was highly suspected as malignant tumor.
Figure 1

Preoperative images. A polycystic cystic echinococcosis (CE) lesion complicated with multiple hepatocellular carcinoma (HCC) nodules in the left lobe of liver (orange arrow represents hepatic CE lesion; white arrow represents HCC lesions). A: Computed tomography (CT) in the arterial phase showing obvious enhancement of the HCC lesions; B: The portal phase of CT revealed a washed-out pattern of the HCC lesions; C: A delayed CT scan showed HCC lesions without significantly retention; D: IQQA-Liver system three-dimensional reconstruction image.

Preoperative images. A polycystic cystic echinococcosis (CE) lesion complicated with multiple hepatocellular carcinoma (HCC) nodules in the left lobe of liver (orange arrow represents hepatic CE lesion; white arrow represents HCC lesions). A: Computed tomography (CT) in the arterial phase showing obvious enhancement of the HCC lesions; B: The portal phase of CT revealed a washed-out pattern of the HCC lesions; C: A delayed CT scan showed HCC lesions without significantly retention; D: IQQA-Liver system three-dimensional reconstruction image.

MULTIDISCIPLINARY EXPERT CONSULTATION

After a multidisciplinary team discussion, the preoperative diagnosis was made of co-occurrence of hepatic polycystic echinococcosis and HCC. According to Romic classification[8], the case was type IIb. The postoperative pathological examination revealed CE co-existence with well-differentiated HCC (Figure 2), consistent with the preoperative diagnosis.
Figure 2

Microscopic histopathology images (× 100). A: Section of specimens showed complete cyst wall structure, consistent with histopathological characteristics of cystic echinococcosis; B: Multiple highly differentiated cancer cells are found in the section specimens.

Microscopic histopathology images (× 100). A: Section of specimens showed complete cyst wall structure, consistent with histopathological characteristics of cystic echinococcosis; B: Multiple highly differentiated cancer cells are found in the section specimens.

FINAL DIAGNOSIS

Co-occurrence of hepatic polycystic echinococcosis and HCC.

TREATMENT

Radical left hemi-hepatectomy was performed (Figure 3).
Figure 3

Intraoperative photos. A and B: The yellow arrows represent hepatic cystic echinococcosis lesions and the white arrows represent hepatocellular carcinoma lesions.

Intraoperative photos. A and B: The yellow arrows represent hepatic cystic echinococcosis lesions and the white arrows represent hepatocellular carcinoma lesions.

OUTCOME AND FOLLOW-UP

The patient recovered and was discharged on the eighth day after the operation and no treatment was received after discharge. The magnetic resonance imaging conducted at 3 mo after surgery showed no significant recurrence of the lesion (Figure 4).
Figure 4

Magnetic resonance images 3 mo after surgery, showing no significant recurrence lesion (A-D).

Magnetic resonance images 3 mo after surgery, showing no significant recurrence lesion (A-D).

DISCUSSION

Hepatic CE and HCC are both liver space-occupying diseases with high incidence, whereas the concomitant presence of hepatic CE and HCC is a fairly rare scenario, leaving evidence-based options of treatments unavailable worldwide. Based on the World Health Organization Informal Working Group on Echinococcosis (known as WHO-IWGE) international classification[7], the current case belongs to the type II hydatid cysts, for which radical resection is recommended to be performed in the guideline. The BCLC staging system is the method currently used to stage HCC and widely accepted as a therapeutic guidance. For the current patient, there were more than three tumors with the size of 35 mm, and the case was considered as intermediate-staged HCC (stage B); furthermore, the lesions were located in the same lobe of the liver. Hemihepatectomy is advised by the European Association for the Study of the Liver clinical practice guideline[9] and the American guideline (2018)[10] for such cases. By applying the guidelines for both diseases, the radical left hemihepatectomy was performed and albendazole therapy for CE and HCC adjuvant therapy were not recommended after surgery. In addition, entecavir was administered since the hepatitis B surface antigen test was positive. To our knowledge, there are few studies on co-infection of CE and HCC and the association between the two is still not well recognized. There are 25 cases reported concerning concomitant HCC and echinococcal cysts in the scientific literature worldwide and 20 of them have provided sufficient data for review analysis. The patients represent 12 males and 8 females, aged from 27 years to 82 years, with an average age of 67. Fifteen of them had underlying chronic liver diseases. It has been reported that CE infection may lead to the development of liver carcinoma[11,12]. By contrast, van Knapen[13] put forward the hypothesis that echinococcus infection could suppress tumor growth. Recently, Bo et al[14] reported 13 patients with co-existence of hepatic CE and HCC, being the report with the largest number of cases at present. Those authors consider that E. granulosus may elicit a protective effect against the development and progression of HCC. The most common cause of HCC is liver cirrhosis caused by hepatitis and other causes[15]. Although our case showed evidence of hepatitis B, there was no cirrhosis or elevation of alpha-fetoprotein. In addition, the tumors were located in the hydatid peripheral normal liver tissues, and there was no tumor in the right lobe of the liver. Therefore, we speculate that a chronic inflammatory reaction of liver tissue around the cyst, especially in the extruded area, may have led to increased risk of HCC development.

CONCLUSION

Based on the case and literature review described herein, the current knowledge may raise a hypothesis that human CE may induce the development of HCC, and increased cyst size and hepatitis B may increase the risk of such. When there is combination of hepatitis B and obvious extrusion by a large hydatid, the HCC risk of the patients might be higher. Nonetheless, further studies are needed to clarify the assumption.
  15 in total

1.  [A resectable case of hepatocellular carcinoma complicated with hepatic alveolar echinococcosis].

Authors:  Takashi Kato; Yasuo Seino; Kohichi Takada; Masumi Maruya; Shunichi Okubo; Hideaki Nakamura; Yoshiyuki Inoue; Takashi Meguro; Shoichi Horita; Taro Oshikiri; Hideyuki Yamada; Yuji Miyasaka; Miyoshi Fujita; Takayuki Morita; Tatsuya Yoshida; Kanako Chikai
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  2003-05

Review 2.  Hepatocellular carcinoma.

Authors:  Hashem B El-Serag
Journal:  N Engl J Med       Date:  2011-09-22       Impact factor: 91.245

3.  [A case of coexistence of primary cancer of the liver and hepatic echinococcosis].

Authors:  A Sygut; A Górski; A Dziki
Journal:  Wiad Lek       Date:  1987-06-15

Review 4.  Echinococcosis: Advances in the 21st Century.

Authors:  Hao Wen; Lucine Vuitton; Tuerhongjiang Tuxun; Jun Li; Dominique A Vuitton; Wenbao Zhang; Donald P McManus
Journal:  Clin Microbiol Rev       Date:  2019-02-13       Impact factor: 26.132

Review 5.  A Synchronous Occurrence of Hepatocellular Carcinoma and Echinoccocal Liver Cyst - Can Parasite Promote Carcinogenesis? Literature Review and Classification Proposal.

Authors:  Bosko Romic; Ivan Romic; Igor Petrovic; Marijan Romic; Renata Romic; Matija Romic; Marko Mance; Goran Pavlek
Journal:  Chirurgia (Bucur)       Date:  2016 Jul-Aug

6.  Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.

Authors:  Jorge A Marrero; Laura M Kulik; Claude B Sirlin; Andrew X Zhu; Richard S Finn; Michael M Abecassis; Lewis R Roberts; Julie K Heimbach
Journal:  Hepatology       Date:  2018-08       Impact factor: 17.425

Review 7.  EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.

Authors: 
Journal:  J Hepatol       Date:  2018-04-05       Impact factor: 25.083

Review 8.  Global Distribution of Alveolar and Cystic Echinococcosis.

Authors:  P Deplazes; L Rinaldi; C A Alvarez Rojas; P R Torgerson; M F Harandi; T Romig; D Antolova; J M Schurer; S Lahmar; G Cringoli; J Magambo; R C A Thompson; E J Jenkins
Journal:  Adv Parasitol       Date:  2017-01-20       Impact factor: 3.870

9.  Co-existence of hepatocellular carcinoma and cystic echinococcosis.

Authors:  Ran Bo; Aimaiti Yasen; Yingmei Shao; Wenbao Zhang; Renyong Lin; Tiemin Jiang; Hao Wen; Hui Xiao; Tuerganaili Aji
Journal:  Infect Agent Cancer       Date:  2020-01-29       Impact factor: 2.965

10.  Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study.

Authors:  Christina Fitzmaurice; Christine Allen; Ryan M Barber; Lars Barregard; Zulfiqar A Bhutta; Hermann Brenner; Daniel J Dicker; Odgerel Chimed-Orchir; Rakhi Dandona; Lalit Dandona; Tom Fleming; Mohammad H Forouzanfar; Jamie Hancock; Roderick J Hay; Rachel Hunter-Merrill; Chantal Huynh; H Dean Hosgood; Catherine O Johnson; Jost B Jonas; Jagdish Khubchandani; G Anil Kumar; Michael Kutz; Qing Lan; Heidi J Larson; Xiaofeng Liang; Stephen S Lim; Alan D Lopez; Michael F MacIntyre; Laurie Marczak; Neal Marquez; Ali H Mokdad; Christine Pinho; Farshad Pourmalek; Joshua A Salomon; Juan Ramon Sanabria; Logan Sandar; Benn Sartorius; Stephen M Schwartz; Katya A Shackelford; Kenji Shibuya; Jeff Stanaway; Caitlyn Steiner; Jiandong Sun; Ken Takahashi; Stein Emil Vollset; Theo Vos; Joseph A Wagner; Haidong Wang; Ronny Westerman; Hajo Zeeb; Leo Zoeckler; Foad Abd-Allah; Muktar Beshir Ahmed; Samer Alabed; Noore K Alam; Saleh Fahed Aldhahri; Girma Alem; Mulubirhan Assefa Alemayohu; Raghib Ali; Rajaa Al-Raddadi; Azmeraw Amare; Yaw Amoako; Al Artaman; Hamid Asayesh; Niguse Atnafu; Ashish Awasthi; Huda Ba Saleem; Aleksandra Barac; Neeraj Bedi; Isabela Bensenor; Adugnaw Berhane; Eduardo Bernabé; Balem Betsu; Agnes Binagwaho; Dube Boneya; Ismael Campos-Nonato; Carlos Castañeda-Orjuela; Ferrán Catalá-López; Peggy Chiang; Chioma Chibueze; Abdulaal Chitheer; Jee-Young Choi; Benjamin Cowie; Solomon Damtew; José das Neves; Suhojit Dey; Samath Dharmaratne; Preet Dhillon; Eric Ding; Tim Driscoll; Donatus Ekwueme; Aman Yesuf Endries; Maryam Farvid; Farshad Farzadfar; Joao Fernandes; Florian Fischer; Tsegaye Tewelde G/Hiwot; Alemseged Gebru; Sameer Gopalani; Alemayehu Hailu; Masako Horino; Nobuyuki Horita; Abdullatif Husseini; Inge Huybrechts; Manami Inoue; Farhad Islami; Mihajlo Jakovljevic; Spencer James; Mehdi Javanbakht; Sun Ha Jee; Amir Kasaeian; Muktar Sano Kedir; Yousef S Khader; Young-Ho Khang; Daniel Kim; James Leigh; Shai Linn; Raimundas Lunevicius; Hassan Magdy Abd El Razek; Reza Malekzadeh; Deborah Carvalho Malta; Wagner Marcenes; Desalegn Markos; Yohannes A Melaku; Kidanu G Meles; Walter Mendoza; Desalegn Tadese Mengiste; Tuomo J Meretoja; Ted R Miller; Karzan Abdulmuhsin Mohammad; Alireza Mohammadi; Shafiu Mohammed; Maziar Moradi-Lakeh; Gabriele Nagel; Devina Nand; Quyen Le Nguyen; Sandra Nolte; Felix A Ogbo; Kelechi E Oladimeji; Eyal Oren; Mahesh Pa; Eun-Kee Park; David M Pereira; Dietrich Plass; Mostafa Qorbani; Amir Radfar; Anwar Rafay; Mahfuzar Rahman; Saleem M Rana; Kjetil Søreide; Maheswar Satpathy; Monika Sawhney; Sadaf G Sepanlou; Masood Ali Shaikh; Jun She; Ivy Shiue; Hirbo Roba Shore; Mark G Shrime; Samuel So; Samir Soneji; Vasiliki Stathopoulou; Konstantinos Stroumpoulis; Muawiyyah Babale Sufiyan; Bryan L Sykes; Rafael Tabarés-Seisdedos; Fentaw Tadese; Bemnet Amare Tedla; Gizachew Assefa Tessema; J S Thakur; Bach Xuan Tran; Kingsley Nnanna Ukwaja; Benjamin S Chudi Uzochukwu; Vasiliy Victorovich Vlassov; Elisabete Weiderpass; Mamo Wubshet Terefe; Henock Gebremedhin Yebyo; Hassen Hamid Yimam; Naohiro Yonemoto; Mustafa Z Younis; Chuanhua Yu; Zoubida Zaidi; Maysaa El Sayed Zaki; Zerihun Menlkalew Zenebe; Christopher J L Murray; Mohsen Naghavi
Journal:  JAMA Oncol       Date:  2017-04-01       Impact factor: 31.777

View more
  2 in total

1.  Hepatocellular Carcinoma Complicated by Echinococcal Cyst: A Case Report.

Authors:  Jiwu Guo; Chenzhe Ma; Xuewen Song; Futian Tang; Lingyun Guo; Jie Mao; Yumin Li
Journal:  Front Surg       Date:  2022-02-02

2.  Hepatocellular Carcinoma Presenting Simultaneously with Echinococcal Cyst Mimicking a Single Liver Lesion in a Non-Cirrhotic Patient: A Case Report and Review of the Literature.

Authors:  Jelena Djokić Kovač; Milica Mitrović; Aleksandra Janković; Marko Andrejević; Aleksandar Bogdanović; Predrag Zdujić; Uroš Đinđić; Vladimir Dugalić
Journal:  Diagnostics (Basel)       Date:  2022-06-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.